Fatty liver index (FLI) was developed as a simple and accurate marker of hepatic steatosis.
FLI is derived from an algorithm based on body mass index, waist circumference, and levels …

Abstract Type 2 diabetes (T2D) and Non-Alcoholic Fatty Liver Disease (NAFLD) are
pathologies whose prevalence continues to increase worldwide. Both diseases are …

Aims Non-alcoholic fatty liver disease (NAFLD) has risen as a significant global public
health issue, for which vertical sleeve gastrectomy (VSG) has become an effective treatment …

Roux-en-Y gastric bypass surgery (RYGB) has shown efficacy in weight loss, but its role in
liver fibrosis remains unknown and contentious. The present study aimed to investigate the …

Background Nonalcoholic fatty liver disease (NAFLD) is a common condition in patients with
obesity. Bariatric surgery has often been proposed as a viable treatment option, but the ideal …

Objective The factors related to the changes in the liver and abdominal adipose tissue
during the rapid weight loss after bariatric surgery remain uncertain. Methods This study …

Patients that undergo bariatric surgery experience weight loss and a reduction in the plasma
levels of the hepatic enzymes alanine aminotransferase (ALT) and aspartate …

Background/Objectives: In metabolic bariatric surgery, structured follow-up protocols may
play an essential role in achieving optimal patient outcomes. This study aims to report …

Introduction Little is known about the prevalence of elevated alkaline phosphatase in post-
bariatric surgery patients due to under-utilization of this test after surgery. Elevated alkaline …

Today, bariatric surgery is the most effective treatment of obesity. Restrictive surgeries are
aimed at reducing the volume of the stomach. Such operations have the least adverse …